Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: Results of the first clinical long-term multicenter study using DALI apheresis

This publication has 19 references indexed in Scilit:

• DALI—the first human whole‐blood low‐density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical results
  European Journal of Clinical Investigation, 1998
• Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia
  The American Journal of Cardiology, 1998
• Long-Term Effects of Low-Density Lipoprotein Apheresis Using an Automated Dextran Sulfate Cellulose Adsorption System fn1fn1This study was supported by a grant from the Kaneka America Corporation, New York, New York.
  The American Journal of Cardiology, 1998
• LDL Hemoperfusion‐A New Procedure for LDL Apheresis: First Clinical Application of an LDL Adsorber Compatible with Human Whole Blood
  Artificial Organs, 1997
• Single LDL Apheresis Improves Endothelium-Dependent Vasodilatation in Hypercholesterolemic Humans
  Circulation, 1997
• LDL-Apheresis Atherosclerosis Regression Study (LAARS)
  Circulation, 1996
• Low-Density Lipoprotein Apheresis Versus Lipid Lowering Drugs in the Treatment of Severe Hypercholesterolemia: Four Years' Experience
  Artificial Organs, 1996
• State of the Art of Lipid Apheresis
  Artificial Organs, 1996
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Lipid Apheresis by Hemoperfusion: In Vitro Efficacy and Ex Vivo Biocompatibility of a New Low‐Density Lipoprotein Adsorber Compatible with Human Whole Blood
  Artificial Organs, 1993